BROUGHT TO YOU BY:

ETF Portfolio Builder

New

ETF Portfolio Builder

New

FHLCvsFTXHETF Comparison

ETF 1

FHLC

Fidelity MSCI Health Care Index ETF

This fund is part of

US Health Care

-1.09%

Full FHLC fund page

VS

ETF 2

FTXH

First Trust Nasdaq Pharmaceuticals ETF

This fund is part of

US Health Care

-1.09%

Full FTXH fund page

Fidelity MSCI Health Care Index ETF (FHLC) and First Trust Nasdaq Pharmaceuticals ETF (FTXH) belong to the same industry segment: US Health Care. FHLC's top 3 sector exposures are Healthcare, Consumer Non-Cyclicals and Business Services. In contrast, FTXH's top sector exposures are Healthcare. FHLC is less expensive with a Total Expense Ratio (TER) of 0.084%, versus 0.6% for FTXH. FHLC is up 16.87% year-to-date (YTD) with +$478M in YTD flows. FTXH performs better with 30.1% YTD performance, and +$1.02B in YTD flows. Run a side-by-side ETF comparison of FHLC and FTXH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios. Discover our library of Model portfolios

FHLC vs FTXH performance and flow charts

Performance

Cumulative Flows

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Data Services

Historic performance and flows

Data as of 10/23/2026

		1M	3M	YTD	1Y	3Y	5Y
Perf.	FHLC FTXH	+5.19%+3.31%	+9.94%+9.99%	+16.87%+30.10%	+24.17%+46.20%	+50.96%+79.92%	+40.36%+75.41%
Flows	FHLC FTXH	+$73M+$41M	+$233M+$980M	+$478M+$1.02B	+$542M+$1.02B	-$187M+$1.02B	+$31M+$1.02B

Volatility and drawdown

		3M	1Y	3Y	5Y
Volatility	FHLC FTXH	+16.94%+18.97%	+15.88%+17.62%	+14.93%+17.18%	+15.51%+16.47%
Max drawdown	FHLC FTXH	-5.64%-5.45%	-10.35%-7.50%	-16.88%-19.32%	-17.78%-19.32%
Max drawdown duration	FHLC FTXH	56d57d	169d99d	435d393d	762d393d

Trading data

Create an account to view trading data

Join for free

	FHLC	FTXH
Last sale 10/26/2026 at 1:30 PM	$86.00	$42.81
Previous close 10/23/2026	$85.99	$42.68
Consolidated volume 10/23/2026
Average volume 30 days
Average discount or premium 30 days
Average Bid/Ask spread 30 days

Replication quality

Data as of September 30, 2026

1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free

	FHLC	FTXH
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst

Main metrics

Last update 10/26/2026 at 1:30 PM

Live

Closed

	FHLC	FTXH
Last price	$86.00	$42.81
1D performance	+0.01%	+0.32%
AuM	$3.82 B	$1.14 B
E/R	0.084%	0.6%

Characteristics

	FHLC	FTXH
Management strategy	Passive	Passive
Provider	Fidelity	First Trust
Benchmark	MSCI USA IMI Health Care 25/50 Index	NASDAQ US Smart Pharmaceuticals Index
N° of holdings	338	49
Asset class	-	Equities
Trailing 12m distribution yield	Join	Join
Inception date	October 21, 2013	September 20, 2016
ESG	No	No

More FHLC data on Trackinsight

More FTXH data on Trackinsight

Exposure

Countries

FHLC

USA

97.14%

Other

2.86%

FTXH

USA

95.82%

Other

4.18%

Sectors

FHLC

Healthcare

98.23%

Other

1.77%

FTXH

Healthcare

99.79%

Other

0.21%

Diversification

FHLC

Total weight of top 15 holdings out of 15

60.85%

FTXH

Total weight of top 15 holdings out of 15

67.15%

Top 15 holdings

Data as of August 31, 2026

FHLC

Eli Lilly & Co.

12.94%

Johnson & Johnson

8.88%

AbbVie, Inc.

6.21%

Merck & Co., Inc.

5.04%

UnitedHealth Group, Inc.

4.91%

Amgen, Inc.

3.21%

Thermo Fisher Scientific, Inc.

3.19%

Abbott Laboratories

2.69%

Gilead Sciences, Inc.

2.49%

Pfizer Inc.

2.19%

Vertex Pharmaceuticals, Inc.

1.90%

Danaher Corp.

1.89%

Bristol Myers Squibb Co.

1.87%

Intuitive Surgical, Inc.

1.82%

CVS Health Corp.

1.63%

FTXH

Merck & Co., Inc.

7.62%

AbbVie, Inc.

7.05%

Eli Lilly & Co.

6.92%

Johnson & Johnson

6.87%

Bristol Myers Squibb Co.

6.75%

Amgen, Inc.

3.56%

Biogen, Inc.

3.54%

Viatris, Inc.

3.51%

Vertex Pharmaceuticals, Inc.

3.48%

Regeneron Pharmaceuticals, Inc.

3.33%

Cardinal Health, Inc.

3.29%

Pfizer Inc.

3.25%

Gilead Sciences, Inc.

3.16%

Incyte Corp.

2.43%

United Therapeutics Corp.

2.39%

Frequently asked questions about FHLC and FTXH

How have the FHLC and FTXH ETFs performed in 2026?

As of October 23, 2026, FHLC is up 16.87% year-to-date (YTD), while FTXH has returned 30.1%. That puts FTXH better performer ahead so far this year.

Which ETF is attracting more investor money: FHLC or FTXH?

Year-to-date, the FHLC ETF saw +$478M in flows, compared to +$1.02B for FTXH.

Which ETF is more volatile: FHLC or FTXH?

Over the past year, FHLC had a volatility of 15.88%, while FTXH experienced 17.62%.

Which ETF is bigger: FHLC or FTXH?

As of October 23, 2026, FHLC holds $3.82 B in assets under management (AUM), while FTXH manages $1.14 B.

What sectors do the FHLC and FTXH ETFs invest in?

FHLC leans toward sectors like Healthcare. Meanwhile, FTXH focuses on Healthcare.

What are the top holdings of the FHLC ETF and FTXH ETF?

FHLC top holdings include Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc.. FTXH holds in its top three: Merck & Co., Inc., AbbVie, Inc. and Eli Lilly & Co..

FHLCvsFTXHETF Comparison

Fidelity MSCI Health Care Index ETF

First Trust Nasdaq Pharmaceuticals ETF

FHLC vs FTXH performance and flow charts

Performance

Cumulative Flows

Get all the metrics on this page, and more, through a reliable ETF data feed

Countries

Sectors

Diversification

Top 15 holdings

How have the FHLC and FTXH ETFs performed in 2026?

As of October 23, 2026, FHLC is up 16.87% year-to-date (YTD), while FTXH has returned 30.1%. That puts FTXH better performer ahead so far this year.

Which ETF is attracting more investor money: FHLC or FTXH?

Year-to-date, the FHLC ETF saw +$478M in flows, compared to +$1.02B for FTXH.

Which ETF is more volatile: FHLC or FTXH?

Over the past year, FHLC had a volatility of 15.88%, while FTXH experienced 17.62%.

Which ETF is bigger: FHLC or FTXH?

As of October 23, 2026, FHLC holds $3.82 B in assets under management (AUM), while FTXH manages $1.14 B.

What sectors do the FHLC and FTXH ETFs invest in?

FHLC leans toward sectors like Healthcare. Meanwhile, FTXH focuses on Healthcare.

What are the top holdings of the FHLC ETF and FTXH ETF?

FHLC top holdings include Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc.. FTXH holds in its top three: Merck & Co., Inc., AbbVie, Inc. and Eli Lilly & Co..

Which ETF is more diversified: FHLC or FTXH?

FHLC holds 338 securities with 60.85% of its assets in the top 15. FTXH has 49 securities and a top 15 weight of 67.15%.

ETFs’ Next Act: From Access to Selection